Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Byron H. Kwan(Massachusetts Institute of Technology), K. Dane Wittrup(Massachusetts Institute of Technology)
Cited by 48
Related Papers
An engineered protein antagonist of K-Ras/B-Raf interaction
|Scientific Reports|2017|65
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
|Proceedings of the National Academy of Sciences|2022|31
Bivalent target-binding bioPROTACs induce potent degradation of oncogenic SHP2
|Journal of Biological Chemistry|2024|11